|نسخه تمام متن
|10 صفحه PDF
- Autofluorescence lifetime images of normal and cancer cells have been observed.
- NADH fluorescence lifetime is shorter in cancer cells than that in normal cells.
- FAD fluorescence lifetime is also shorter in cancer cells than that in normal cell.
- NADH or FAD fluorescence lifetime measurements are applicable for diagnosis of cancer cells.
- Time-resolved autofluorescence spectra of NADH were measured for normal and cancer cells.
Intracellular fluorescence lifetime images of the endogenous fluorophores of nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD), which are well known as autofluorescence chromophores, were obtained from rat normal fibroblast cells (WFB) and H-ras oncogene-transfected cancer cells among WFB (W31). The average lifetime of the NADH and FAD autofluorescence was shorter in cancer cells than in normal cells, indicating that the difference in metabolism between healthy and cancer cells alters the conditions for coenzymes such as NADH and FAD and that the autofluorescence lifetime measurement of NADH and FAD is applicable for the noninvasive diagnosis of cancer cells. The pico- and nano-second time-resolved fluorescence spectra of NADH obtained with different time windows were similar in normal and cancer cells, indicating that every fluorescence decay component gives the same spectrum in both cell types. These results as well as the fluorescence lifetime images of exogenous fluorophores stained with sodium pheophorbide a in normal and cancer cells suggest that the difference in the fluorescence lifetime between normal and cancer cells cannot be attributed to a difference in the intracellular pH or refractive index but to the difference in the bound condition between proteins and NADH or FAD under the different intracellular environments of normal and cancer cells.
Journal: Journal of Photochemistry and Photobiology B: Biology - Volume 165, December 2016, Pages 256-265